Petrus Trust Company, Lta Harvard Bioscience Inc Transaction History

Petrus Trust Company, Lta

  • $949 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $15,135 - $25,298
-5,464 Reduced 28.37%
13,798 $39,000
Q4 2023

Feb 14, 2024
SELL
$4.0 - $5.49 $8,092 - $11,106
-2,023 Reduced 9.5%
19,262 $103,000
Q3 2023

Nov 14, 2023
BUY
$4.0 - $5.82 $85,140 - $123,878
21,285 New
21,285 $91,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email